News
The deal has a value of up to $330 million, with the final price tied to future sales of Optinose's flagship product.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback